Back to results
US 2020/0206152 A1Published application
7-oh-cannabidiol (7-oh-cbd) and/or 7-oh-cannabidivarin (7-oh-cbdv) for use in the treatment of epilepsy
AssigneeGW Research Limited
InventorsColin Stott, Nick Jones, Benjamin Whalley, Gary Stephens, Claire Williams
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of 7-hydroxy-cannabidol (7-OH-CBD) and/or 7-hydroxy-cannabidivarin (7-OH-CBDV) in the treatment of epilepsy. Preferably the cannabinoid metabolites are isolated from plants to produce a highly purified extract or can be reproduced synthetically.
Claims18
-10. (canceled)
A method of treating epilepsy comprising administering a therapeutically effective amount of 7-hydroxy-cannabidiol (7-OH-CBD) to a subject in need thereof.
A pharmaceutical composition comprising 7-hydroxy-cannabidiol (7-OH-CBD) with a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.